UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 22, 2022
Martin Marietta Materials, Inc.
(Exact name of registrant as specified in its charter)
North Carolina
|
|
56-1848578
|
(State or other jurisdiction |
001-12744
|
(IRS Employer |
of incorporation) |
(Commission File Number) |
Identification No.) |
4123 Parklake Avenue
|
|
Raleigh, North Carolina |
27612
|
(Address of principal executive offices) |
(Zip Code) |
Registrant’s telephone number, including area code: 919
781-4550
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class
|
Trading Symbol
|
Name of Each Exchange
|
|
|
on Which Registered
|
Common Stock, $.01 par value per share
|
MLM
|
The New York Stock Exchange
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this
chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01 Entry into a Material
Definitive Agreement
On December 22, 2022, Martin Marietta Materials, Inc. (the “Corporation”) entered into a Loan Modification No. 1 and Extension Agreement (the
“Amendment”) with JPMorgan Chase Bank, N.A. (“JPMCB”) and the Lenders (as defined in the Amendment) to the Corporation’s $800,000,000 five-year senior unsecured revolving credit facility with JPMCB, as administrative agent, Deutsche Bank Securities
Inc., PNC Bank, National Association, Truist Bank, and Wells Fargo Bank, National Association as co-syndication agents and the lenders party thereto (the “Credit Agreement”).
The Amendment amends the Credit Agreement to, among other things, (i) extend the maturity date of the loans advanced under the Credit Agreement to
December 21, 2027, and (ii) replace the London InterBank Offered Rate “LIBOR” with the Secured Overnight Financing Rate “SOFR” as the interest rate benchmark.
The full text of the Amendment is filed as Exhibit 10.1 hereto and is incorporated herein by reference. The description of the First Amendment and
Credit Agreement contained herein are qualified in their entirety by the terms of the First Amendment and the amended and restated Credit Agreement.
Item 2.03 Creation of a Direct Financial
Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
The information required by Item 2.03 is included under Item 1.01 “Entry into a Material Definitive Agreement” and that information is incorporated herein by reference.
Item 9.01 Financial Statements and
Exhibits
(d) Exhibits
|
|
|
|
|
|
|
|
|
104
|
|
The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
|
MARTIN MARIETTA MATERIALS, INC.
|
|
|
|
|
|
Date: December 22, 2022 |
By:
|
/s/ Roselyn R. Bar |
|
|
|
Name: |
Roselyn R. Bar
|
|
|
|
Title: |
Executive Vice President, General Counsel and Corporate Secretary
|
|
|
|
|
|